Sandip Basu

49PUBLICATIONS

33CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Oral and maxillofacial surgeryCancer diagnosisMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (49)

Sort by Publication Date:

|Jul 11, 2026

Correction to: Inter- and intra-quartile comparison of multi-tracer PET/CT and liquid biopsy molecular markers in cancer: a futuristic perspective on evolving a "stepped care" model for individualized precision theranostics through AI/ML.

|Jul 03, 2026

Observation on Discordant Treatment Response on [ 18 F]FDG and [ 68 Ga]Ga-FAPI-04 PET/CT in Radioiodine-Refractory Thyroid Carcinoma Treated with Lenvatinib.

|Jul 01, 2026

Clinical performance of [68Ga]Ga-DOTA-FAPI-04 PET/CT in detecting recurrent disease in medullary thyroid carcinoma: a comparative analysis with [18F]F-FDG and [68Ga]Ga-DOTATATE PET/CT, alongside identification of suitable candidates for targeted radionuclide therapy.

|Jun 25, 2026

Inter- and intra-quartile comparison of multi-tracer PET/CT and liquid biopsy molecular markers in cancer: a futuristic perspective on evolving a "stepped care" model for individualized precision theranostics through AI/ML.

|May 22, 2026

Efficacy of intra-arterial [177Lu]Lu-DOTATATE vs. continuation intravenous [177Lu]Lu-DOTATATE peptide receptor radionuclide therapy in nonresponding locally advanced inoperable or liver-dominant metastatic gastroenteropancreatic neuroendocrine tumors.

|May 16, 2026

Multi-tracer PET reveals profound biological uncoupling in metastatic grade 3 pancreatic NET: beyond the Mib1 index.

Pageof 9

Frequent Collaborators

Sunita Sonavane

Yeshwanth Edamadaka

Bhakti Basu

Sharmila Banerjee

Ashwini Kalshetty

Mahesh Kumar Padwal

Ashwini Chalikandy

Nivedita Chakrabarty

Abhishek Mahajan

Kimberly Perez

Frequent Collaborators

Sunita Sonavane

Yeshwanth Edamadaka

Bhakti Basu

Sharmila Banerjee